Introduction: The goal of continuing medical education (CME) is professional growth and improved patient care. We sought to determine if a curriculum of CME activities could improve the clinical knowledge, competence, and confidence of diabetologists/endocrinologists (D/Es), pediatricians and primary care physicians (PCPs) related to T1D.
Methods: The educational curriculum consisted of 3 online activities, all of which used repeated pairs pre-/post-assessment study design and McNemar’s test (P <.05 is considered significant) to assess educational effect. The activities launched from March to May, 2023, and data were collected for up to 12 weeks for each activity.
Results: The education reached over 24,000 clinicians, including >1,600 D/Es, >1,700 pediatricians, and >2,900 PCPs. Overall, improvements were seen across all target audiences and in all topics, including overall relative improvements of 45% among D/Es, 60% among pediatricians, and 78% among PCPs. Additionally, the proportion of learners who demonstrated improvements/reinforcement of knowledge/competence, the education positively impacted 96% of D/Es, 89% of pediatricians, and 83% of PCPs. This resulted in significant improvements in confidence. Knowledge/competence improvement related to staging T1D: 118% D/Es, 152% pediatricians, and 179% PCPs (relative changes, all P<.001).
Knowledge/competence improvement related to treating T1D: 17% D/Es, 38% pediatricians, and 45% PCPs (relative changes, all P<.001). Knowledge/competence improvement related to educating patients about T1D: 88% D/Es, 65% pediatricians, and 88% PCPs (relative changes, all P<.001).
Conclusion: This curriculum demonstrated success in educating on this topic, with significant increases in knowledge, competence, and confidence of clinicians related to staging, treating and educating patients about T1D.
A. Larkin: None. A. Le: None.
Developed through an independent educational grant from Provention Bio, a Sanofi Company.
